• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过三维生物打印制备的聚己内酯植入物中丙戊酸盐的释放

Valproate release from polycaprolactone implants prepared by 3D-bioplotting.

作者信息

Kammerer M, Fabritius M, Carvalho C, Mülhaupt R, Feuerstein T J, Trittler R

机构信息

Section of Clinical Neuropharmacology, Department of Neurosurgery, Albert-Ludwigs University, Freiburg, Germany.

出版信息

Pharmazie. 2011 Jul;66(7):511-6.

PMID:21812326
Abstract

In this study we examined the release kinetics of valproate from polycaprolactone (PCL) implants constructed for local antiepileptic therapy. The PCL implants were produced with a novel 3D-Bioplotting technology. Release kinetics were determined by superfusion of these implants. Valproate was measured in the superfusate fractions with high pressure liquid chromatography (HPLC). The HPLC measurements were linear over a concentration range of 10-500 microg/mL for valproate and the limit of quantification was found to be 9 microg/mL. The HPLC method used is simple, accurate and sensitive. Within the first day, valproate (10% w/w)-PCL implants released already 77% of the maximum possible liberated amount whereas (5% w/w)-PCL implants released only 53%. After four days, 88% of valproate was released from (10% w/w)-PCL implants and 94% valproate from (5% w/w)-PCL implants. When valproate was ground before the 3D-Bioplotting process, only 63% from (10% w/w)-PCL implants was released within the first day. This released amount of ground valproate was significantly lower compared to that which was not ground from the (10% w/w)-PCL implants. After three days of superfusion a total amount of 89% of ground valproate within the implants was released, corresponding to 88% of non-ground valproate after four days. The fast releasing PCL implants can be used to study acute effects of locally applied valproate on epileptogenesis in vivo after initiation of an epileptic focus in an animal model. The corresponding biocompatibility may also be analysed.

摘要

在本研究中,我们检测了用于局部抗癫痫治疗的聚己内酯(PCL)植入物中丙戊酸盐的释放动力学。PCL植入物采用新型3D生物打印技术制造。通过对这些植入物进行超灌流来测定释放动力学。用高压液相色谱法(HPLC)测定超灌流液组分中的丙戊酸盐。丙戊酸盐在10 - 500μg/mL浓度范围内,HPLC测量呈线性,定量限为9μg/mL。所采用的HPLC方法简便、准确且灵敏。在第一天内,含10%(重量/重量)丙戊酸盐的PCL植入物已释放出最大可能释放量的77%,而含5%(重量/重量)丙戊酸盐的PCL植入物仅释放了53%。四天后,含10%(重量/重量)丙戊酸盐的PCL植入物释放了88%的丙戊酸盐,含5%(重量/重量)丙戊酸盐的PCL植入物释放了94%的丙戊酸盐。当丙戊酸盐在3D生物打印过程之前进行研磨时,含10%(重量/重量)丙戊酸盐的PCL植入物在第一天内仅释放了63%。与未研磨的含10%(重量/重量)丙戊酸盐的PCL植入物相比,研磨后的丙戊酸盐释放量明显更低。超灌流三天后,植入物中研磨后的丙戊酸盐总量释放了89%,相当于未研磨的丙戊酸盐四天后的释放量88%。快速释放的PCL植入物可用于研究在动物模型中癫痫病灶形成后,局部应用丙戊酸盐对体内癫痫发生的急性影响。相应的生物相容性也可进行分析。

相似文献

1
Valproate release from polycaprolactone implants prepared by 3D-bioplotting.通过三维生物打印制备的聚己内酯植入物中丙戊酸盐的释放
Pharmazie. 2011 Jul;66(7):511-6.
2
Gravity spun polycaprolactone fibres: controlling release of a hydrophilic macromolecule (ovalbumin) and a lipophilic drug (progesterone).重力纺聚己内酯纤维:控制亲水性大分子(卵清蛋白)和疏水性药物(孕酮)的释放。
Biomaterials. 2004 Sep;25(20):5053-60. doi: 10.1016/j.biomaterials.2004.02.027.
3
Effects of implant diameter, drug loading and end-capping on praziquantel release from PCL implants.载药聚己内酯植入物中药物的释放与植入物直径、载药量和端封的关系。
Int J Pharm. 2010 Feb 15;386(1-2):23-9. doi: 10.1016/j.ijpharm.2009.10.046. Epub 2009 Nov 4.
4
Pharmacokinetic characteristics of a new multiple unit sustained release formulation of sodium valproate.丙戊酸钠新型多单元缓释制剂的药代动力学特征
Int J Clin Pharmacol Ther. 1999 Feb;37(2):100-8.
5
New amphiphilic and pH-sensitive hydrogel for controlled release of a model poorly water-soluble drug.新型两亲性和 pH 敏感水凝胶用于控制模型疏水性药物的释放。
Eur J Pharm Biopharm. 2009 Nov;73(3):345-50. doi: 10.1016/j.ejpb.2009.07.008. Epub 2009 Jul 23.
6
Novel PCL-based honeycomb scaffolds as drug delivery systems for rhBMP-2.新型基于聚己内酯的蜂窝状支架作为重组人骨形态发生蛋白-2的药物递送系统。
Biomaterials. 2005 Jun;26(17):3739-48. doi: 10.1016/j.biomaterials.2004.09.052.
7
Precipitation casting of drug-loaded microporous PCL matrices: incorporation of progesterone by co-dissolution.载药微孔聚己内酯基质的沉淀浇铸法:通过共溶解法掺入孕酮
J Control Release. 2005 Sep 2;106(3):263-72. doi: 10.1016/j.jconrel.2005.05.013.
8
The effect of elastin on chondrocyte adhesion and proliferation on poly (ɛ-caprolactone)/elastin composites.弹性蛋白对聚(己内酯)/弹性蛋白复合材料上软骨细胞黏附和增殖的影响。
Biomaterials. 2011 Feb;32(6):1517-25. doi: 10.1016/j.biomaterials.2010.10.024. Epub 2010 Nov 27.
9
Physicochemical characterisation and biological evaluation of hydrogel-poly(epsilon-caprolactone) interpenetrating polymer networks as novel urinary biomaterials.水凝胶-聚(ε-己内酯)互穿聚合物网络作为新型泌尿生物材料的物理化学表征及生物学评价
Biomaterials. 2005 May;26(14):1761-70. doi: 10.1016/j.biomaterials.2004.06.002.
10
In vitro and in vivo evaluation of praziquantel loaded implants based on PEG/PCL blends.基于 PEG/PCL 共混物的吡喹酮植入剂的体内外评价。
Int J Pharm. 2010 Mar 15;387(1-2):129-38. doi: 10.1016/j.ijpharm.2009.12.010. Epub 2009 Dec 18.

引用本文的文献

1
Locally applied valproate enhances survival in rats after neocortical treatment with tetanus toxin and cobalt chloride.局部应用丙戊酸可提高破伤风毒素和氯化钴处理新皮质后大鼠的存活率。
Biomed Res Int. 2013;2013:497485. doi: 10.1155/2013/497485. Epub 2013 Sep 14.